Seeking Alpha

Enzon Pharmaceuticals, Inc. (ENZN)

  • Mar. 19, 2013, 6:39 AM
    Enzon Pharmaceuticals (ENZN): Q4 EPS of -$0.11. Revenue of $10.6M. (PR)
    | Mar. 19, 2013, 6:39 AM | Comment!
Visit Seeking Alpha's
ENZN vs. ETF Alternatives
Company Description
Enzon Pharmaceuticals Inc is related to sales of drugs by various companies. It generates revenues from the sales of products namely, PegIntron, Sylatron, Macugen and CIMZIA.
Sector: Healthcare
Industry: Biotechnology
Country: United States